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Introduction
Matrix metalloproteinases (MMPs) represent an inter-
esting family of zinc-dependent enzymes that belong to
the class of metalloproteinases, which are essential
effectors of developmental processes, balanced by their
tissue inhibitors of metalloproteinases (TIMPs). They
are participating in the processes of cell migration, cell
proliferation, apoptosis and tissue morphogenesis regu-
lating the function of biologically active molecules. The
MMPs also fulfill an important role in endothelial cell
invasion, angiogenesis and in tumor progression [1-5]. 
The degradative matrix metalloproteinase play an
important role in remodeling a number of tissues, and
because they are only enzymes capable of degrading the
components of the extracellular matrix they are likely to
play a role in the remodeling of the collagen rich, extra-
cellular matrix of the fetal membranes, including the
marked disruption of the connective tissue layers in the
cervical area [6,7].
Metalloproteinase-8, also known as collagenase-2 or
neutrophil collagenase, which common substrates are:
collagens I-III, α2-macroglobulin, α1-proteinase
inhibitor, C1q, fibrinogen, substance P. Like most
MMPs, MMP-8 is secreted as an inactive pro-enzyme
that needs to be activated before it can exert its function.
This pro-form of MMP-8 contains an N-terminal pro-
domain with the cysteine residue that interacts with the
Zn2+ ion at the active site to block all proteolytic activi-
ty. Only by disrupting this mechanism can the pro-
enzyme be converted into an active protease [5].
The aim of this study was to measure the concen-
tration of a total forms of MMP-8 in serum during
physiological pregnancy, threatened preterm labour
patients, as well as in preterm and term labouring
patients, to assess the role of MMP-8 in pathogenesis
of preterm labour. 
Materials and methods
Patients. Patients were divided into four groups:  I  (n=25) –
women at gestational age 24-34 weeks of pregnancy without any
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symptoms of preterm labour (physiological pregnancy); II (n=16)
– threatened preterm labour patients with uterine contractility at
gestational age 24-34 weeks of pregnancy with intact fetal mem-
branes; III (n=22) – preterm vaginal delivery patients with preterm
premature rapture of fetal membranes; IV (n=35) – control term
vaginal delivery patients with premature rapture of fetal mem-
branes. Prior consent for the study was obtained from the Local
Bioethical Committee of Medical University of Bia³ystok, which
accepted study protocol. Gestational age of patients was calculated
according to the date of last menstrual period confirmed by first
trimester ultrasound examination. The study excluded the patients
who had administered the antibiotic therapy within the last 3
weeks, multiple pregnancy, chorioamnionitis, cervical cerclage,
vaginal bleeding, placenta praevia, diabetes and renal disease in
pregnancy. All labouring patients and threatened preterm labour
patients had regular uterine contractility at least 3 hours before
obtained blood sample. All patients were primiparas. In all preterm
and term labouring patients, premature rapture of fetal membranes
have place in the first stage of labour and blood samples were
obtained after ruptures of membranes. The time from premature
rapture of fetal membranes to delivery was not longer than 6 hours.
Clinical characteristics of patients are shown in Table 1.
MMP-8 concentration assessment. The total MMP-8 serum lev-
els were measured in plasma samples with the using enzyme-
linked immunosorbent assays (MMP-8, Human, Biotrak ELISA
System, Amersham Biosciences).
Statistical analysis. For statistical analysis comparison of mean
values of total MMP-8 between four groups of patients was per-
formed by analysis of variance (ANOVA). The statistical analysis
was performed using PRISM (GraphPad, US) and SAS STAT
(SAS Institute, US) packages. The 0.05 significance level was
applied.
Results 
No statistically significant differences in the median
serum concentrations of total MMP-8 was found
between four studied groups of patients (p=0.046).
(Fig. 1). The mean values of MMP-8 concentrations in
each study group and standard deviations are present-
ed in Table 2, but these results were not statistically
significant (p=0.21).
Discussion
Despite of recent development in perinatology and
prenatal treatment, the mechanisms of induction of
preterm uterine contractility remains still unknown.
From the other site, the costs of prenatal and neonatal
care are still rising. Therefore, it is important to find
non-invasive and non-expensive method allow to pre-
dict preterm delivery [8-11]. 
Approximately 50% of cases of preterm labour are
associated with preterm premature rapture of fetal mem-
branes (pPROM). In the pathogenesis of preterm labour,
several interrelated mechanisms are included. Firstly,
production and release of inflammatory cytokines may
lead to increased prostaglandin secretion [5, 12].
Secondly, pPROM and its consequence – preterm
labour may be initiated by many factors such as infec-
tion, drugs or others [13]. There is also an evidence sup-
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Table 1. Clinical characteristics of four groups of studied patients
Group I – patients at gestational age without any symptoms of preterm labour; Group II – threatened preterm labour patients; 
Group III – preterm vaginal delivery; Group IV – term vaginal delivery
Table 2. The mean values ( SD) total MMP-8 serum concentrations in each study group
Group I – patients at gestational age without any symptoms of preterm labour; Group II – threatened preterm labour patients; 
Group III – preterm vaginal delivery; Group IV – term vaginal delivery
Fig. 1. Median values of total MMP-8 concentrations in studied
groups (p=0.046).
porting the implication of matrix metalloproteins and
their depredating enzymes in the processes of preterm
and term labour as well as that of pPROM [13-15]. 
A programmed collagenolytic remodeling process
exists in fetal membranes during pregnancy to accom-
modate them to the increasing uterine pressure and
volume. This process is mediated by metalloproteinas-
es. There are a number of regulatory mechanisms that
can influence on the MMPs' dependent extracellular
matrix degradation. Regulation occurs at the transcrip-
tional level, translational level, post-translational level
(activation of zymogen forms of MMPs) and at the tis-
sue level by specific regulators known as the tissue
inhibitors of metalloproteinases (TIMPs). A balanced
activity between MMPs and TIMPs has been docu-
mented during tissue remodeling in several systems.
The role of MMPs in human labour and pPROM has
been a subject of considerable study over the last
decade. Increased collagenolysis, a drop in the colla-
gen content of the membranes and activation of MMPs
have been documented during active stage of labour
[13-16]. 
Research studies have already confirmed a signifi-
cant role of many MMPs in mechanism of labour. The
expression of MMP-1, MMP-2, MMP-3, MMP-9,
MMP-10, MMP-11 mRNA was confirmed in amnion
and chorion in preterm as well as in term patients. It
was also investigated that amniotic fluid concentration
of  MMP-1, MMP-2 and MMP-3 increase during the
labour [16-21]. MMP-7 and MMP-8 mRNA were not
found in amniochorionic tissue, but MMP-8 was
detected in the amniotic fluid. In amniotic fluid con-
centration of MMP-8 also raised during the active
stage of labour [21-23]. There was not found research
studies confirming the role of MMP-12 and MMP-13
with pPROM patients.
The elevation of MMP-14 concentration and
decrease in TIMP-2 concentration, resulting in activa-
tion of MMP-2 [23]. Maymon et al. [19] reported that
amniotic concentrations of active forms of MMP-2
were significantly lower in patients with spontaneous
labour at term, term and preterm rupture of membranes
as well as in intrauterine infection connected with
preterm premature rupture of fetal membranes. The
participation of these metalloproteinases in the mecha-
nisms of labour, rupture of membranes and intrauterine
infection it seem to be clear. The activity of metallo-
proteinase-2 is also increased in amniotic fluid in
preterm premature rupture of membranes [23].  
Koscica et al. study [12] on animal model confirmed
the role of metalloproteinases MMP-1, MMP-2, MMP-
3, MMP-8 and MMP-9 in the preterm parturition process
complicated by inflammatory factors. They hypothe-
sized that administration of a MMP inhibitor would
reduce the rate of inflammation-mediated preterm deliv-
ery and prolong gestation in a mouse model. 
Biggio et al. [24] showed that, the overall distribu-
tion of MMP-8 concentration in amniotic fluid was
comparable in preterm patients with premature rupture
of membranes and in term delivered patients. One
fourth part of patients with pPROM had a MMP-8 con-
centration above the 90th percentile, in comparison
with only 10% of term controls. The overall distribu-
tion of mid trimester amniotic fluid, MMP-8 concen-
tration did not differ between women with pPROM
and delivered at term. 
Yonemoto et al. [25] confirmed that increased
matrix metalloproteinase (MMP)-9 activity is associat-
ed with term birth, preterm birth and premature rupture
of membranes. MMP-9 pro-enzyme activities in the
amnion increased significantly with labour at term,
and were higher than at preterm labour. There were no
changes in chorion MMP-9 activity between studied
groups. They also suggested MMP-2 may be another
regulator of membrane rupture and other labour-asso-
ciated mechanisms at term parturition, bur its need
more clinical trials.
According to Maymon et al. study [26], authors
showed a role of matrix metalloproteinase-8 as a sen-
sitive marker of intrauterine infection and preterm
labour  in patients with intact membranes. The rate of
preterm delivery was 54% and that of intra-amniotic
infection was 9.2%. The median amniotic fluid matrix
metalloproteinase-8 concentration was more than 50-
fold higher in patients with intra-amniotic infection
than in patients without. The matrix MMP-8 amniotic
fluid concentrations were significantly higher in
patients who delivered preterm than in patients who
delivered at term. After exclusion of patients with
intra-amniotic infection, patients who delivered
preterm had a significantly higher median amniotic
fluid matrix metalloproteinase-8 than patients who
delivered at term. An amniotic fluid MMP-8 concen-
tration cut-off level >30 ng/mL was an predictor factor
of increased neonatal morbidity.
At another study by Maymon et al. [27] authors
investigated, if MMP-8 amniotic fluid concentration
changed in preterm and term labour according to influ-
ence of premature rupture of fetal membranes or intra-
amniotic infection. Spontaneous rupture of membranes
in preterm patients was associated with elevated amni-
otic fluid MMP-8 concentrations. Microbial invasion
of the amniotic cavity was associated with a signifi-
cantly higher MMP-8 concentration in preterm
patients with intact membranes, as well as ruptured
membranes.
In all studies presented above, the invasive diag-
nostic amnicenthesis procedure was used to asses the
MMPs concentration in the amniotic fluid. This proce-
dure is strictly connected with the increased risk of
materno-fetal complications. Therefore, it is so impor-
tant to find non-invasive diagnostic method being
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helpful to find a sensitive predictive marker of preterm
labour. It seems to be in value to look for the predic-
tive factors in serum, urine or cervical mucus.
In our previous studies [28,29] we evaluate the con-
centrations of active and total MMP-2 and TIMP-2 in
serum and urine in preterm labour patients at 24-36
weeks of pregnancy, threatened preterm labour
patients at 24-36 weeks of pregnancy and patients
delivered at term. No significant differences in the
concentrations of active MMP-2, total MMP-2 and
TIMP-2 were found between studied groups 
Makrakis et al. [30] reported that plasma and urine
MMP-9 levels were significantly higher and serum
and urine TIMP-1 were significantly lower in patients
with spontaneous uterine contractions term and
preterm delivering patients, in comparison to non-
labouring patients. According to authors' hypothesis
the elevated plasma and urine concentration of MMP-
9 could possibly identify the inevitable progress of
uterine contractility to final preterm labour.
Sorokin et al. [31] evaluated the maternal serum
concentration of interleukin-6 (IL-6), C-Reactive
Protein (CRP), and matrix metalloproteinase-9 (MMP-
9) as potential predictive  factors of preterm delivery.
Among the patients, who have any symptoms of
threatened preterm delivery and intact membranes,
only maternal serum concentrations of IL-6 and CRP,
but not MMP-9 were associated with higher risk of
preterm delivery <32 weeks.
Botsis et al. [32] assessed the value of plasma
MMP-9 levels in predicting the progress of threatened
preterm labour to preterm delivery within 7 days of
presentation together with the ultrasonographic meas-
urement of cervical length. Study showed that plasma
MMP-9 levels could possibly serve as a predictive fac-
tor for the progress of threatened preterm labour to true
preterm labour and delivery within 7 days of presenta-
tion, along with the ultrasound evaluation of cervical
length. 
Choi et al. [33] investigated the changes of matrix
metalloproteinase-9 (MMP-9) in cervicovaginal fluid
during pregnancy and its association with term partu-
rition. Cervicovaginal MMP-9 concentration did not
change significantly with advancing gestation until 37
weeks, and significantly increased after 37 weeks. Cer-
vicovaginal MMP-9 levels were similar in non-labour-
ing pregnant women, spontaneous term labour patients
and premature rupture of membranes patients at term. 
Considering the difficulties in finding ideal predic-
tive marker of preterm delivery, as well as differentiate
biochemical activities of MMPs, we may conclude,
that the studies on the larger population are needed to
reject the hypothesis that preterm labour is connected
with increased MMP-8 plasma concentrations of
women in preterm labour and threatened preterm
delivery. 
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